Showing 19,841 - 19,860 results of 104,685 for search '(( i wt decrease ) OR ( 5 ((fold decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.13s Refine Results
  1. 19841

    Data from showing mean ± SEM of circulating parasitaemia (red) and TPB (blue) in the 10 mice. by Deborah Cromer (282682)

    Published 2013
    “…Green shaded area highlights the data that is used in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0055961#pone-0055961-g007" target="_blank">Figure 7</a> and indicates an increase in the growth rate of the TPB after day 5 coupled with a decrease in the growth rate of parasitaemia.…”
  2. 19842
  3. 19843
  4. 19844
  5. 19845
  6. 19846

    Group mean changes in gait cycle duration during knee perturbation trial and aftereffect. by Kailey Nishimura (6167213)

    Published 2018
    “…<p>(A) Shows the change in gait cycle period percentage of the full amplitude knee perturbation condition with decreasing electrical stimulation period. …”
  7. 19847

    Two Mutations in the Caprine <i>MTHFR</i> 3'UTR Regulated by MicroRNAs Are Associated with Milk Production Traits by Jinxing Hou (771646)

    Published 2015
    “…<div><p>Background</p><p>5,10-Methylenetetrahydrofolate reductase (MTHFR) plays a central role in folate metabolism by irreversibly converting 5,10-methylenetetrahydrofolate to 5-methylenetetrahydrofolate, a predominant circulating form of folate. …”
  8. 19848
  9. 19849

    Differences between G signals complementary to unmethylated C residues, -methylcytosine residues and 5-methylcytosine residues using the DYEnamic ET Terminator Kit by A. Bart (10517)

    Published 2011
    “…-methylcytosine results in an increase in the complementary G signal, whereas 5-methylcytosine results in a decrease in the complementary G signal.…”
  10. 19850
  11. 19851
  12. 19852

    Isothermal Titration Calorimetric and Computational Studies on the Binding of Chitooligosaccharides to Pumpkin (<i>Cucurbita maxima</i>) Phloem Exudate Lectin by Akkaladevi Narahari (2209924)

    Published 2011
    “…The dimeric PPL binds to (GlcNAc)<sub>3−5</sub> with binding constants of 1.26−1.53 × 10<sup>5</sup> M<sup>−1</sup> at 25 °C, whereas chitobiose exhibits approximately 66-fold lower affinity. …”
  13. 19853

    Isothermal Titration Calorimetric and Computational Studies on the Binding of Chitooligosaccharides to Pumpkin (<i>Cucurbita maxima</i>) Phloem Exudate Lectin by Akkaladevi Narahari (2209924)

    Published 2011
    “…The dimeric PPL binds to (GlcNAc)<sub>3−5</sub> with binding constants of 1.26−1.53 × 10<sup>5</sup> M<sup>−1</sup> at 25 °C, whereas chitobiose exhibits approximately 66-fold lower affinity. …”
  14. 19854
  15. 19855

    Therapeutic effects of scFv-hD6-Ec and scFv-h3D6-Pp. by Laia Montoliu-Gaya (4329709)

    Published 2017
    “…<p><b>(A) Viability assays in SH-SY5Y neuroblastoma cell line</b>. …”
  16. 19856
  17. 19857
  18. 19858
  19. 19859

    Evaluating the Potential of Ozone Microbubbles for Inactivation of Tulane Virus, a Human Norovirus Surrogate by Bozhong Guan (18598178)

    Published 2024
    “…After 2, 10, and 20 min postgeneration, the ozone concentration of microbubbles naturally decreased from 4 ppm to 3.2 ± 0.2, 2.26 ± 0.19, and 1.49 ± 0.23 ppm and resulted in 1.43 ± 0.44, 0.88 ± 0.5, and 0.68 ± 0.53 log<sub>10</sub> viral reductions, respectively, while the ozone concentration of aqueous ozone decreased from 4 ppm to 2.52 ± 0.07, 0.43 ± 0.05, and 0.09 ± 0.01 ppm and produced 0.8 ± 0.28, 0.29 ± 0.41, and 0.16 ± 0.21 log<sub>10</sub> reductions against Tulane virus, respectively (<i>p</i> = 0.0526), suggesting that structuring of ozone in the bubbles over the applied treatment conditions did not have a significant effect, though future study with continuous generation of ozone microbubbles is needed.…”
  20. 19860

    A visual summary of the key study findings. by Joachim Worthington (8394213)

    Published 2024
    “…Modelling was used to estimate short- and long-term effects on colorectal cancer incidence and mortality, including ongoing impact of patient backlogs. A hypothetical mitigation strategy was simulated, with diagnostic and treatment capacities increased by 5% from 2022 to address backlogs. …”